| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| vTv Therapeutics Inc. | President and CEO, Director | Employee stock option (right to buy) | 2.5M | $29.5M | $11.81 | Oct 19, 2021 | Direct |
| Design Therapeutics, Inc. | Director | Common Stock | 23.8K | $55.9K | $2.35 | Aug 29, 2023 | Direct |
| Design Therapeutics, Inc. | Director | Stock Option (right to buy) | 19K | Jun 13, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| DSGN | Design Therapeutics, Inc. | Jun 13, 2024 | 1 | $0 | 4 | Jun 17, 2024 | Director |
| DSGN | Design Therapeutics, Inc. | Aug 29, 2023 | 1 | $27.7K | 4 | Aug 30, 2023 | Director |
| DSGN | Design Therapeutics, Inc. | May 31, 2023 | 1 | $0 | 4 | Jun 2, 2023 | Director |
| DSGN | Design Therapeutics, Inc. | Jun 15, 2022 | 1 | $0 | 4 | Jun 16, 2022 | Director |
| DSGN | Design Therapeutics, Inc. | Mar 16, 2022 | 1 | $0 | 4 | Mar 18, 2022 | Director |
| VTVT | vTv Therapeutics Inc. | Oct 19, 2021 | 1 | $0 | 4 | Oct 21, 2021 | President and CEO, Director |
| VTVT | vTv Therapeutics Inc. | Oct 19, 2021 | 0 | $0 | 3 | Oct 21, 2021 | President and CEO, Director |
| DSGN | Design Therapeutics, Inc. | Jun 15, 2021 | 1 | $0 | 4 | Jun 16, 2021 | Director |
| DSGN | Design Therapeutics, Inc. | Jun 15, 2021 | 0 | $0 | 3 | Jun 16, 2021 | Director |